Investing Theriva Biologics stock soars after EMA backs Phase 3 trial design Dylan D. DavisDecember 29, 2025 Theriva Biologics stock soars after EMA backs Phase 3 trial design Source link
European stocks mixed, Sanofi buys Dynavax; France condemns U.S. visa ban European stocks mixed, Sanofi buys Dynavax; France condemns U.S. visa ban Source link
Israel stocks higher at close of trade; TA 35 up 0.55% Israel stocks higher at close of trade; TA 35 up 0.55% Source link
Indonesia stocks higher at close of trade; IDX Composite Index up 0.18% Indonesia stocks higher at close of trade; IDX Composite Index up 0.18% Source link
